Cencora Inc. (COR) support and resistance · P/E 21, rev $321.33B
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
This page maps Cencora Inc. (COR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
COR currently screens at market cap $53.91B and trailing P/E 21.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new COR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the COR quote page for the session range and the stock page for the full model.
Not investment advice.